Hutch News

Hutch News

Stories tagged 'Leukemia'

Lyani Valle: Leukemia survivor, Obliteride walker

'Cancer was a huge wake-up call to what is important in life'

Aug. 3, 2018 | By Sabin Russell / Fred Hutch News Service

Obliteride walker Lyani Valle, a program manager at Amazon, survived a rare form of leukemia using a therapy made possible by Fred Hutch research.

View story >


Acclaimed author and oncologist Dr. Siddhartha Mukherjee visits Fred Hutch

'If you are not preventing, curing and treating cancer, you are off target. You have not achieved the mandate.'

July 24, 2018 | By Sabin Russell / Fred Hutch News Service

Acclaimed author and oncologist Dr. Siddhartha Mukherjee visited Fred Hutchinson Cancer Research Center to talk about his wriitings and his cancer research

View story >


3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant

$20M renewal of 4-decade-long federal grant to Hutch scientists

May 31, 2018 | By Susan Keown / Fred Hutch News Service

The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.

View story >


Pacific NW Magazine profiles Fred Hutch’s pursuit of cancer cures

Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible

May 17, 2018 | By Fred Hutch staff

Cover story of Seattle Times’ Pacific NW Magazine explores why Fred Hutchinson Cancer Research Center is closing in on cancer cures.

View story >


Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal

T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers

April 16, 2018 | By Rachel Tompa / Fred Hutch News Service

In an effort to improve the efficacy of immunotherapy for solid tumors, Fred Hutch researchers have engineered a new type of protein that can rewire a 'kill switch' to stimulate T cells' activity instead.

View story >


How does leukemia escape from immunotherapy?

New tech enables deep dive into mysterious results, sets stage for future improvements

April 16, 2018 | By Susan Keown / Fred Hutch News Service

“We don’t stop asking what we can do better”: Fred Hutch researchers delve into failures to learn how to improve an experimental cancer immunotherapy.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.